Cargando…
Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study
Erythropoietic medications such as including erythropoietin (EPO) are known to be neuroprotective and to correlate with improved cognitive functions. However, it is not known whether supplementation with EPO reduces the risk of dementia in end-stage renal disease (ESRD) patients receiving hemodialys...
Autores principales: | Hung, Peir-Haur, Yeh, Chih-Ching, Sung, Fung-Chang, Hsiao, Chih-Yen, Muo, Chih-Hsin, Hung, Kuan-Yu, Tsai, Kuen-Jer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756878/ https://www.ncbi.nlm.nih.gov/pubmed/31484803 http://dx.doi.org/10.18632/aging.102227 |
Ejemplares similares
-
Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan
por: Hung, Peir‐Haur, et al.
Publicado: (2021) -
End stage renal disease is associated with development of dementia
por: Hung, Peir-Haur, et al.
Publicado: (2017) -
The Association of Erythropoietin and Age-Related Macular Degeneration in Hemodialysis Patients: A Nationwide Population-Based Cohort Study
por: Huang, Evelyn-Jou-Chen, et al.
Publicado: (2022) -
Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan
por: Hsu, Yueh-Han, et al.
Publicado: (2015) -
Increased Risk of End-Stage Renal Disease in Patients with Renal Cell Carcinoma: A 12-Year Nationwide Follow-Up Study
por: Hung, Peir-Haur, et al.
Publicado: (2014)